H. G. Prentice - Concepedia

Author

H. G. Prentice

Also Known As

H G PRENTICE, H G Prentice, H Grant Prentice, H. G. Prentice, H. GRANT PRENTICE, H. Grant Prentice, H.G. Prentice, H.Grant Prentice, H. G. Prentice, H. Grant Prentice

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University College London The Royal Free Hospital Integrated Cardio Metabolic Centre The Christie Hospital The Honourable Society of Lincoln's Inn

About

H. G. Prentice is an author at University College London specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	28	2.2K
2	Health Sciences	10	10	686
3	Allergy	2	2	302
4	Engineering	1	1	44
5	Natural Sciences	1	1	36

H. G. Prentice

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study Rajesh Chopra, J.D. Eaton, Anna Grassi, British Journal of Haematology	2000	183
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation Christian Gisselbrecht, H. G. Prentice, Almalina Bacigalupo, The Lancet TransplantationBone-marrow TransplantationMarrow TransplantationStem Cell TransplantationHematology	1994	172
Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey Dan Engelhard, Catherine Cordonnier, Peter J. Shaw, British Journal of Haematology TransplantationStem Cell TransplantationClinical EpidemiologyTransplantation MedicineClinical Infection	2002	169
Intravenous Itraconazole Followed by Oral Itraconazole in the Treatment of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies, Chronic Granulomatous Disease, or AIDS Denis Caillot, Harry P. Bassaris, Allison McGeer, Clinical Infectious Diseases	2001	160
Reconstitution of EBV-Specific T Cell Immunity in Solid Organ Transplant Recipients Tanzina Haque, P L Amlot, Nabeela Helling, The Journal of Immunology Solid Organ TransplantationImmunologyBlood CellPathologyImmunotherapy	1998	153
Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura Jo Howard, A. V. Hoffbrand, H. G. Prentice, British Journal of Haematology ImmunohematologyImmunodeficienciesImmunologyImmunotherapyThrombosis	2002	151
Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases George Janossy, A. V. Hoffbrand, Melvyn F. Greaves, British Journal of Haematology Mixed-phenotype Acute LeukemiaImmunologyDiagnosisPathologyImmunophenotyping	1980	151
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study Rajesh Chopra, J.D. Eaton, Anna Grassi, British Journal of Haematology GastroenterologyPathologyPharmacotherapySurgeryCompassionate Grounds	2000	128
Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases Francesco Frassoni, A. John Barrett, A Grañena, British Journal of Haematology Mixed-phenotype Acute LeukemiaBone Marrow TransplantImmunologyPathologyImmunotherapy	1988	120
Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia Forida Y. Mortuza, Mary Papaioannou, Ilidia M. Moreira, Journal of Clinical Oncology Mrd PositivityMolecular MarkersMixed-phenotype Acute LeukemiaImmunodeficienciesImmunology	2002	115

Page 1